Description: NKMAX CO., Ltd. manufactures and supplies proteins and monoclonal antibodies worldwide. The company provides anti-cancer immunotherapy treatment that activates the immune cells in body to kill the cancer cells; natural killer cell activity test for cancer patients; and health supplements. It also offers NK PUPPY, a test that measures dog's immunity. The company was formerly known as ATGen Co and changed name to NKMAX CO., Ltd. in 2019. NKMAX CO., Ltd. was founded in 2002 and is headquartered in Seongnam, South Korea.
Home Page: www.nkmax.com
172, Dolma-ro
Seongnam-si,
13605
South Korea
Phone:
82 31 8017 8114
Officers
| Name | Title |
|---|---|
| Sang-Woo Park | Chief Exec. Officer |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 52.0124 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 132 |